Welcome to our dedicated page for DuPont de Nemours SEC filings (Ticker: DD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
DuPont de Nemours, Inc. filings document the regulatory disclosures of a Delaware specialty materials company with common stock listed on the New York Stock Exchange under DD. Its 8-K reports cover operating and financial results, Regulation FD disclosures, material events, board composition changes, corporate-governance matters and capital-structure disclosures.
DuPont proxy materials describe annual stockholder voting matters, director elections, governance practices, executive compensation and proposals affecting the company’s certificate of incorporation and common stock. Recent filings also document separation-related matters, including disclosures connected with the completed Qnity Electronics spin-off, as well as agreements and percentage calculations tied to the post-separation corporate structure.
State Street Corporation reported passive ownership of DuPont de Nemours, Inc. common stock on a Schedule 13G. State Street beneficially owned 6,958,558 shares of DuPont common stock, representing 5.1% of the class. The filing shows no sole voting or dispositive power, with 4,340,855 shares subject to shared voting power and 6,950,668 shares subject to shared dispositive power. The holdings are attributed to various asset management and banking subsidiaries, including SSGA Funds Management, Inc., State Street Bank and Trust Company, and multiple State Street Global Advisors entities across the U.S., Europe, Asia, Australia, and Saudi Arabia. The disclosure notes that no other person is identified as having rights to receive dividends or sale proceeds exceeding 5% of the class.
DuPont de Nemours, Inc. is conducting an exchange offer for up to $684,398,000 principal amount of its privately placed 4.725% Notes due 2028 (the “Original Notes”) for a like principal amount of registered 4.725% Notes due 2028 (the “Exchange Notes”). The exchange is made to satisfy obligations under a registration rights agreement and will not change total indebtedness; Original Notes received will be retired and canceled. The Exchange Notes have the same financial terms and covenants as the Original Notes but are freely tradable, subject to standard securities law limitations for affiliates and certain broker‑dealers.
DuPont reports a reverse stock split of 1‑for‑3, effective June 24, 2026, and recasts share and EPS data. For 2025, income from continuing operations attributable to common stockholders was $88 million, or $0.63 basic and diluted EPS, while total net loss available to common stockholders was $779 million, or $(5.60) basic EPS, driven by discontinued operations. Weighted‑average basic shares were 139.2 million and common shares outstanding at year‑end 2025 were 136,398,482. The filing outlines detailed risks, including the unsecured and nonguaranteed status of the notes, potential illiquidity if holders do not participate in the offer, change‑of‑control repurchase mechanics, interest‑rate sensitivity, and limited covenants protecting noteholders.
DuPont de Nemours, Inc. reported Q2 2026 net sales of $1,819 million, up from $1,749 million a year earlier. Income from continuing operations rose to $191 million, or basic EPS of $1.38, compared with $24 million and $0.17. Net income attributable to common stockholders was $143 million.
For the first six months, net sales were $3,500 million and operating cash provided by continuing operations increased to $632 million from $151 million, supporting cash and cash equivalents of $1,740 million and long-term debt of $3,125 million at June 30, 2026.
On April 1, 2026 DuPont completed the $1.8 billion Aramids business divestiture, receiving approximately $1.2 billion in cash, a $300 million note receivable and a 16 percent equity interest valued at $325 million; Aramids and the previously separated Electronics business are presented as discontinued operations.
DuPont continues to address legacy PFAS matters under a Memorandum of Understanding with Chemours and Corteva. Indemnification liabilities accrued under this framework and related litigation were $530 million at June 30, 2026, including a $188 million accrual for the proposed $875 million New Jersey settlement and a $125 million liability related to State of North Carolina matters. A 1-for-3 reverse stock split became effective June 24, 2026, leaving 135,042,975 shares outstanding at July 31, 2026.
DuPont de Nemours, Inc. reported second quarter 2026 results, with net sales of $1.8 billion, up 4% on 4% organic growth, and adjusted EPS from continuing operations of $1.88, up 48% versus a year earlier, while exceeding its second quarter 2026 guidance and raising full‑year 2026 guidance.
GAAP income from continuing operations was $191 million (GAAP EPS $1.37), and operating EBITDA rose to $448 million with a 24.6% margin. Cash provided by operating activities from continuing operations was $400 million, and transaction‑adjusted free cash flow reached $326 million, a 127% conversion. The company plans to repurchase $250 million of shares in the third quarter, now expects full‑year 2026 operating EBITDA of about $1.76 billion and adjusted EPS around $7.24, and has changed its GICS code to Industrials following portfolio moves including the $1.2 billion Aramids business sale and a 1‑for‑3 reverse stock split effective June 24, 2026.
DuPont de Nemours, Inc. implemented a 1-for-3 reverse stock split of its common stock, together with a proportional reduction in the number of authorized common shares. These changes, previously approved by stockholders and the Board, were effected through a Certificate of Amendment to the company’s Third Amended and Restated Certificate of Incorporation.
The Certificate of Amendment became effective at 12:01 a.m. Eastern Time on June 24, 2026, followed one minute later by a restated charter reflecting the amendment. The company’s common stock will continue to trade on the New York Stock Exchange under the ticker symbol DD, with a new CUSIP number 26614N 201.
DuPont de Nemours, Inc. CEO Lori Koch reported two common stock transactions. She had 4,672.5058 shares withheld at $48.03 per share to cover taxes on lapsed RSUs and related dividend-equivalent units, a non-market, compensation-related disposition. She also executed an open-market sale of 260.9784 shares at $48.82 per share within her 401(k) retirement savings plan. According to the disclosure, this 401(k) sale was voluntarily initiated ahead of the planned elimination of the company stock fund as an investment option, and the proceeds were immediately reinvested in other plan investment options. After these transactions, she directly holds 345,172.0573 shares and retains a very small indirect balance of 0.0204 shares in the retirement plan.
DuPont de Nemours, Inc. SVP & CFO Antonella B. Franzen reported a routine tax-withholding transaction related to equity compensation. On May 31, 2026, 1,558.1826 shares of DuPont common stock were disposed of at $48.03 per share to cover tax obligations on lapsed restricted stock units (RSUs) and related dividend equivalent units. This was not an open-market sale, but shares withheld by the issuer for taxes. After this transaction, Franzen directly holds 68,808.5975 shares of DuPont common stock.
DuPont de Nemours director Donald G. Macpherson received a stock award of 671.2102 shares of Common Stock on May 29, 2026, valued at $48.42 per share. This was a grant or other acquisition reported on Form 4 and is compensation-related rather than an open-market purchase. Following the award, he directly holds a total of 5,867.88 shares.
Lowery Frederick M. reported acquisition or exercise transactions in this Form 4 filing.
DuPont de Nemours, Inc. director Frederick M. Lowery received a stock award of 800.2891 shares of Common Stock. The shares were granted at a price of $48.42 per share as a compensation-related award, not an open-market purchase. After this grant, his directly held stake increased to 40,205.482 shares, indicating a relatively small, routine addition to his overall holdings.
DuPont de Nemours, Inc. director Alexander M. Cutler received a stock award of 1,032.6311 shares of Common Stock. The award was recorded at a value of $48.42 per share and is classified as a grant or other acquisition, not an open-market purchase.
Following this equity grant, Cutler directly holds a total of 81,794.4041 shares of DuPont Common Stock. This appears to be a routine compensation-related equity award that increases his ownership stake in the company.